Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ELPLAT Cause Hyperammonaemia? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hyperammonaemia have been filed in association with ELPLAT. This represents 10.5% of all adverse event reports for ELPLAT.

6
Reports of Hyperammonaemia with ELPLAT
10.5%
of all ELPLAT reports
1
Deaths
2
Hospitalizations

How Dangerous Is Hyperammonaemia From ELPLAT?

Of the 6 reports, 1 (16.7%) resulted in death, 2 (33.3%) required hospitalization, and 1 (16.7%) were considered life-threatening.

Is Hyperammonaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ELPLAT. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does ELPLAT Cause?

Interstitial lung disease (12) Neuropathy peripheral (10) Neutrophil count decreased (8) White blood cell count decreased (7) Diarrhoea (5) Nausea (5) Platelet count decreased (5) Splenomegaly (5) Stomatitis (5)

What Other Drugs Cause Hyperammonaemia?

VALPROIC ACID (581) VALPROATE (328) FLUOROURACIL (263) DIVALPROEX (256) LEVETIRACETAM (192) TACROLIMUS (181) ACETAMINOPHEN (177) OXALIPLATIN (160) TOPIRAMATE (156) GLYCEROL PHENYLBUTYRATE (147)

Related Pages

ELPLAT Full Profile All Hyperammonaemia Reports All Drugs Causing Hyperammonaemia ELPLAT Demographics